4 天之前 · Dupixent may be used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis (EOE), or prurigo nodularis. Dupixent is given as a subcutaneous injection every 1 to 4 weeks. People can be taught how to self-administer it.

2024年10月10日 · Dupixent (generic name: dupilumab) is approved to treat certain age groups with eczema (atopic dermatitis), asthma, chronic rhinosinusitis (sinus and nasal cavity swelling) with nasal polyps (tissue growths), chronic obstructive pulmonary disease (COPD), eosinophilic esophagitis, and prurigo nodularis (a skin condition).

2024年10月3日 · Easy-to-read patient tips for Dupixent covering how it works, benefits, risks, and best practices.

2024年10月6日 · DUPIXENT is an interleukin-4 receptor alpha antagonist indicated: Atopic Dermatitis. for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

2024年9月27日 · Preparation for Use. Before injection, remove DUPIXENT from the refrigerator and allow DUPIXENT to reach room temperature (45 minutes for the 300 mg/2 mL pre-filled syringe or pre-filled pen, and 30 minutes for the 200 mg/1.14 mL pre-filled syringe or pre-filled pen) without removing the needle cap.

2025年1月13日 · Dupilumab (brand name Dupixent) may be used to treat eczema (atopic dermatitis [AD]), eosinophilic or oral-corticosteroid-dependent asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis (EOE), or prurigo nodularis. Dupilumab is self-administered by subcutaneous (under the skin) injection every 1 …

2023年3月28日 · For healthcare professionals. Applies to dupilumab: subcutaneous solution. General adverse events. The most common adverse reactions were injection site reactions (which included erythema, edema, pruritus, pain, and swelling), conjunctivitis, allergic conjunctivitis, arthralgia, oral herpes, and eosinophilia.

2024年10月3日 · Official answer: No, Dupixent (dupilumab) is not an immunosuppressant or a steroid. Dupixent works by targeting a type of protein called...

2024年10月7日 · Dupixent is associated with several different eye problems, including conjunctivitis, blepharitis, dry eyes, itchy eyes, and keratitis.

2024年10月3日 · Official answer: Dupixent (dupilumab) is associated with several different eye problems, including conjunctivitis, blepharitis, dry...